Skip to main content
Top
Published in: Virchows Archiv 4/2010

Open Access 01-04-2010 | Meeting Report

The role of the pathologist in tissue banking: European Consensus Expert Group Report

Authors: Generoso Bevilacqua, Fred Bosman, Thibaut Dassesse, Heinz Höfler, Anne Janin, Rupert Langer, Denis Larsimont, Manuel M. Morente, Peter Riegman, Peter Schirmacher, Giorgio Stanta, Kurt Zatloukal, Elodie Caboux, Pierre Hainaut

Published in: Virchows Archiv | Issue 4/2010

Login to get access

Abstract

Human tissue biobanking encompasses a wide range of activities and study designs and is critical for application of a wide range of new technologies (-“omics”) to the discovery of molecular patterns of disease and for implementation of novel biomarkers into clinical trials. Pathology is the cornerstone of hospital-based tissue biobanking. Pathologists not only provide essential information identifying the specimen but also make decisions on what should be biobanked, making sure that the timing of all operations is consistent with both the requirements of clinical diagnosis and the optimal preservation of biological products. This document summarizes the conclusions of a Pathology Expert Group Meeting within the European Biological and Biomolecular Research Infrastructure (BBMRI) Program. These recommendations are aimed at providing guidance for pathologists as well as for institutions hosting biobanks on how to better integrate and support pathological activities within the framework of biobanks that fulfill international standards.
Literature
1.
go back to reference Riegman PH, Dinjens WN, Oosterhuis JW (2007) Biobanking for interdisciplinary clinical research. Pathobiology 74:239–244CrossRefPubMed Riegman PH, Dinjens WN, Oosterhuis JW (2007) Biobanking for interdisciplinary clinical research. Pathobiology 74:239–244CrossRefPubMed
2.
go back to reference Riegman PH, Morente MM, Betsou F et al (2008) Biobanking for better healthcare. Mol Oncol 2:213–222CrossRefPubMed Riegman PH, Morente MM, Betsou F et al (2008) Biobanking for better healthcare. Mol Oncol 2:213–222CrossRefPubMed
3.
go back to reference Morente MM, Fernandez PL, de Alava E (2008) Biobanking: old activity or young discipline? Semin Diagn Pathol 25:317–322CrossRefPubMed Morente MM, Fernandez PL, de Alava E (2008) Biobanking: old activity or young discipline? Semin Diagn Pathol 25:317–322CrossRefPubMed
4.
go back to reference Asslaber M, Zatloukal K (2007) Biobanks: transnational, European and global networks. Brief Funct Genomic Proteomic 6:193–201CrossRefPubMed Asslaber M, Zatloukal K (2007) Biobanks: transnational, European and global networks. Brief Funct Genomic Proteomic 6:193–201CrossRefPubMed
5.
go back to reference Pukkala E, Andersen A, Berglund G et al (2007) Nordic biological specimen banks as basis for studies of cancer causes and control–more than 2 million sample donors, 25 million person years and 100,000 prospective cancers. Acta Oncol 46:286–307CrossRefPubMed Pukkala E, Andersen A, Berglund G et al (2007) Nordic biological specimen banks as basis for studies of cancer causes and control–more than 2 million sample donors, 25 million person years and 100,000 prospective cancers. Acta Oncol 46:286–307CrossRefPubMed
6.
go back to reference Ioannidis JP, Adami HO (2008) Nested randomized trials in large cohorts and biobanks: studying the health effects of lifestyle factors. Epidemiology 19:75–82CrossRefPubMed Ioannidis JP, Adami HO (2008) Nested randomized trials in large cohorts and biobanks: studying the health effects of lifestyle factors. Epidemiology 19:75–82CrossRefPubMed
7.
go back to reference Brand AM, Probst-Hensch NM (2007) Biobanking for epidemiological research and public health. Pathobiology 74:227–238CrossRefPubMed Brand AM, Probst-Hensch NM (2007) Biobanking for epidemiological research and public health. Pathobiology 74:227–238CrossRefPubMed
8.
go back to reference Srivastava S, Gopal-Srivastava R (2002) Biomarkers in cancer screening: a public health perspective. J Nutr 132:2471S–2475SPubMed Srivastava S, Gopal-Srivastava R (2002) Biomarkers in cancer screening: a public health perspective. J Nutr 132:2471S–2475SPubMed
9.
go back to reference Srinivas PR, Kramer BS, Srivastava S (2001) Trends in biomarker research for cancer detection. Lancet Oncol 2:698–704CrossRefPubMed Srinivas PR, Kramer BS, Srivastava S (2001) Trends in biomarker research for cancer detection. Lancet Oncol 2:698–704CrossRefPubMed
10.
go back to reference Scheel JR, Kuo MD (2006) Exploring the human genome in cancer with genomic approaches. J Vasc Interv Radiol 17:1225–1233CrossRefPubMed Scheel JR, Kuo MD (2006) Exploring the human genome in cancer with genomic approaches. J Vasc Interv Radiol 17:1225–1233CrossRefPubMed
11.
go back to reference Rai AJ (2007) Biomarkers in translational research: focus on discovery, development and translation of protein biomarkers to clinical immunoassays. Expert Rev Mol Diagn 7:545–553CrossRefPubMed Rai AJ (2007) Biomarkers in translational research: focus on discovery, development and translation of protein biomarkers to clinical immunoassays. Expert Rev Mol Diagn 7:545–553CrossRefPubMed
12.
go back to reference Maruvada P, Wang W, Wagner PD et al (2005) Biomarkers in molecular medicine: cancer detection and diagnosis. Biotechniques Suppl:9–15 Maruvada P, Wang W, Wagner PD et al (2005) Biomarkers in molecular medicine: cancer detection and diagnosis. Biotechniques Suppl:9–15
13.
go back to reference Caboux E, Plymoth A, Hainaut P (2007) Common minimal technical standards and protocols for Biological Resource Centers dedicated to Cancer Research. IARC Working Group Reports 2:1–38 Caboux E, Plymoth A, Hainaut P (2007) Common minimal technical standards and protocols for Biological Resource Centers dedicated to Cancer Research. IARC Working Group Reports 2:1–38
14.
go back to reference Betsou F, Barnes R, Burke T et al (2009) Human biospecimen research: experimental protocol and quality control tools. Cancer Epidemiol Biomarkers Prev 18:1017–1025CrossRefPubMed Betsou F, Barnes R, Burke T et al (2009) Human biospecimen research: experimental protocol and quality control tools. Cancer Epidemiol Biomarkers Prev 18:1017–1025CrossRefPubMed
15.
go back to reference Knoppers BM, Fortier I, Legault D et al (2008) The Public Population Project in Genomics (P3G): a proof of concept? Eur J Hum Genet 16:664–665CrossRefPubMed Knoppers BM, Fortier I, Legault D et al (2008) The Public Population Project in Genomics (P3G): a proof of concept? Eur J Hum Genet 16:664–665CrossRefPubMed
16.
go back to reference Moore HM, Compton CC, Lim MD et al (2009) 2009 Biospecimen research network symposium: advancing cancer research through biospecimen science. Cancer Res 69:6770–6772CrossRefPubMed Moore HM, Compton CC, Lim MD et al (2009) 2009 Biospecimen research network symposium: advancing cancer research through biospecimen science. Cancer Res 69:6770–6772CrossRefPubMed
17.
go back to reference Riegman PH, Dinjens WN, Oomen MH et al (2006) TuBaFrost 1: uniting local frozen tumour banks into a European network: an overview. Eur J Cancer 42:2678–2683CrossRefPubMed Riegman PH, Dinjens WN, Oomen MH et al (2006) TuBaFrost 1: uniting local frozen tumour banks into a European network: an overview. Eur J Cancer 42:2678–2683CrossRefPubMed
18.
19.
go back to reference Vaught JB, Lockhart N, Thiel KS et al (2007) Ethical, legal, and policy issues: dominating the biospecimen discussion. Cancer Epidemiol Biomarkers Prev 16:2521–2523CrossRefPubMed Vaught JB, Lockhart N, Thiel KS et al (2007) Ethical, legal, and policy issues: dominating the biospecimen discussion. Cancer Epidemiol Biomarkers Prev 16:2521–2523CrossRefPubMed
20.
go back to reference Lemrow SM, Colditz GA, Vaught JB et al (2007) Key elements of access policies for biorepositories associated with population science research. Cancer Epidemiol Biomarkers Prev 16:1533–1535CrossRefPubMed Lemrow SM, Colditz GA, Vaught JB et al (2007) Key elements of access policies for biorepositories associated with population science research. Cancer Epidemiol Biomarkers Prev 16:1533–1535CrossRefPubMed
21.
go back to reference Van Veen EB, Riegman PH, Dinjens WN et al (2006) TuBaFrost 3: regulatory and ethical issues on the exchange of residual tissue for research across Europe. Eur J Cancer 42:2914–2923CrossRefPubMed Van Veen EB, Riegman PH, Dinjens WN et al (2006) TuBaFrost 3: regulatory and ethical issues on the exchange of residual tissue for research across Europe. Eur J Cancer 42:2914–2923CrossRefPubMed
22.
go back to reference Riboli E (2001) The European Prospective Investigation into Cancer and Nutrition (EPIC): plans and progress. J Nutr 131:170S–175SPubMed Riboli E (2001) The European Prospective Investigation into Cancer and Nutrition (EPIC): plans and progress. J Nutr 131:170S–175SPubMed
Metadata
Title
The role of the pathologist in tissue banking: European Consensus Expert Group Report
Authors
Generoso Bevilacqua
Fred Bosman
Thibaut Dassesse
Heinz Höfler
Anne Janin
Rupert Langer
Denis Larsimont
Manuel M. Morente
Peter Riegman
Peter Schirmacher
Giorgio Stanta
Kurt Zatloukal
Elodie Caboux
Pierre Hainaut
Publication date
01-04-2010
Publisher
Springer-Verlag
Published in
Virchows Archiv / Issue 4/2010
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-010-0887-7

Other articles of this Issue 4/2010

Virchows Archiv 4/2010 Go to the issue